Metabolic & Inflammatory Support as Part of Psychiatric Care
If mood, anxiety, or energy have been difficult to stabilize—especially alongside changes in weight, appetite, inflammation, or metabolic health—there may be underlying biological factors affecting brain-body communication. These patterns are not a failure of willpower, but often reflect neuroinflammatory and metabolic stress that can directly impact mental health.
At Grounded Psychiatry in Atlanta, we provide psychiatric-led, medically supervised care that addresses how inflammation, metabolism, stress physiology, sleep, and brain chemistry interact with mood and emotional well-being.
As part of a comprehensive psychiatric evaluation, GLP-1–based medications may be considered when clinically appropriate to support inflammation reduction, metabolic stability, and medication tolerance, particularly when these factors are contributing to mood symptoms, fatigue, or difficulty responding to psychiatric treatment.
Medication is only one part of care. Support is integrated within a root-cause, functional psychiatry approach, addressing contributors such as inflammation, stress physiology, sleep, hormones, nutrition, and nervous system regulation as they relate to mental health.
The focus is on safe, thoughtful, long-term psychiatric stability and quality of life—not quick fixes or one-size-fits-all solutions.
-
GLP-1 medications, such as semaglutide and tirzepatide, act on brain–gut signaling pathways involved in blood sugar regulation, inflammation, and metabolic stress. These pathways also influence mood, energy, cognition, and emotional regulation.
In psychiatric care, GLP-1–based medications may be used to support metabolic stability and inflammation reduction when these factors are contributing to mood symptoms, fatigue, or difficulty responding to traditional psychiatric treatment.
-
Compounded GLP-1 medications are prepared by licensed specialty pharmacies when commercial products are unavailable or when individualized dosing is clinically appropriate.
At Grounded Psychiatry, compounded medications are considered only when they support psychiatric care goals and are sourced exclusively from trusted compounding pharmacies that meet strict quality and safety standards.
-
Yes. Long-term psychiatric stability comes from addressing the whole picture. When GLP-1–based medications are used, they are integrated into a psychiatric treatment plan that may include nervous system regulation, sleep support, nutrition guidance, stress physiology care, and lab-guided interventions.
These supports are designed to improve mental health outcomes and quality of life, not to replace foundational care.
-
GLP-1–based medications may be considered for adults receiving psychiatric care when metabolic or inflammatory factors are interfering with mental health, such as:
Mood or energy symptoms associated with insulin resistance or metabolic stress
Psychiatric medication side effects impacting metabolic health or treatment adherence
Inflammation-associated depression, fatigue, or cognitive symptoms
During your consultation, we review your psychiatric history, labs, and overall clinical picture to determine whether this approach aligns with your mental health treatment goals.
-
Treatment costs vary depending on your individualized psychiatric care plan, including whether adjunctive metabolic or anti-inflammatory support is clinically appropriate. All options are discussed transparently during your evaluation.
-
GLP-1–based medications are offered only as adjuncts to psychiatric care. Grounded Psychiatry does not provide primary weight-loss programs, obesity treatment, or standalone metabolic care.
Ready for Support?
If feeling clear, steady, and emotionally well has felt harder than it should, your nervous system and metabolism may be asking for deeper support. We would love to help you feel grounded, resilient, and confident again.
